Evidence map›Paper›PMID 22276116›Full record

ArticlePloS one2012

Production and characterization of antifungal compounds produced by Lactobacillus plantarum IMAU10014.

HaiKuan Wang, YanHua Yan, JiaMing Wang, HePing Zhang, Wei Qi

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Review
  3. Antifungal effect and some properties of cell-free supernatants of two Bacillus subtilis isolates against Fusarium verticillioides.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  4. Article
  5. Antagonistic properties ofFrontiers in microbiology · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Antifungal activity of probiotic strainFrontiers in microbiology · 2023
    Article
  13. Article
  14. Macrolactin A mediated biocontrol ofFrontiers in microbiology · 2023
    Article
  15. Article
  16. Screening ofMicroorganisms · 2022
    Article
  17. Review
  18. Antifungal Activity ofFoods (Basel, Switzerland) · 2022
    Article
  19. Impact ofFrontiers in microbiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

HaiKuan WangKey Laboratory of Industrial Fermentation Microbiology, Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, People's Republic of China. haikuanwangcn@yahoo.com.cn
YanHua Yan
JiaMing Wang
HePing Zhang
Wei Qi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactobacillus plantarum IMAU10014 was isolated from koumiss that produces a broad spectrum of antifungal compounds, all of which were active against plant pathogenic fungi in an agar plate assay. Two major antifungal compounds were extracted from the cell-free supernatant broth of L. plantarum IMAU10014. 3-phenyllactic acid and Benzeneacetic acid, 2-propenyl ester were carried out by HPLC, LC-MS, GC-MS, NMR analysis. It is the first report that lactic acid bacteria produce antifungal Benzeneacetic acid, 2-propenyl ester. Of these, the antifungal products also have a broad spectrum of antifungal activity, namely against Botrytis cinerea, Glomerella cingulate, Phytophthora drechsleri Tucker, Penicillium citrinum, Penicillium digitatum and Fusarium oxysporum, which was identified by the overlay and well-diffusion assay. F. oxysporum, P. citrinum and P. drechsleri Tucker were the most sensitive among molds.

Indexed as

Antifungal AgentsBotrytisChromatography, High Pressure LiquidFusariumGas Chromatography-Mass SpectrometryLactiplantibacillus plantarumMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsPenicilliumPhenylacetatesAntifungal AgentsPhenylacetates

Identifiers

PMID22276116
PMCPMC3261852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.